- 2-FDCK
- 2F-Ketamine
- 2F-Deschloroketamine
- 2-F-2′-Oxo-PCM
- 2-Fluoro-deschloroketamine
EMCDDA. New drugs in Europe, 2016, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2017. 489 kB. #54
Moghimi, A; Rahmani, S; Zare, R; Sadeghzadeh, M. Synthesis of 2-(2-fluorophenyl)-2-methylamino-cyclohexanone as a new ketamine derivative Synth. Commun., 18 Jul 2014, 44 (14), 2021–2028. 266 kB. https://doi.org/10.1080/00397911.2014.885053 #5
Wallach, J; Brandt, SD. 1,2-Diarylethylamine- and ketamine-based new psychoactive substances In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 305-352. 593 kB. https://doi.org/10.1007/164_2018_148 #2-FDCK
Dimitrov, I; Denny, W; Jose, J. Syntheses of ketamine and related analogues: A mini review Synthesis, 1 Nov 2018, 50 (21), 4201–4215. 793 kB. https://doi.org/10.1055/s-0037-1609935 #F-ketamine, 73
Hägele, JS; Basrak, M; Schmid, MG. Enantioselective separation of novel psychoactive substances using a Lux® AMP 3 μm column and HPLC-UV J. Pharm. Biomed. Anal., 5 Feb 2020, 179, 112967. 3.6 MB. https://doi.org/10.1016/j.jpba.2019.112967 #E4 LC
Angenoorth, TJF; Stankovic, S; Niello, M; Holy, M; Brandt, SD; Sitte, HH; Maier, J. Interaction profiles of central nervous system active drugs at human organic cation transporters 1–3 and human plasma membrane monoamine transporter Int. J. Mol. Sci., 30 Nov 2021, 22 (23), 12995. 5.1 MB. https://doi.org/10.3390/ijms222312995 #2-Fluoro-deschloroketamine
Kruegel, AC; Sames, D; Hashimoto, K. Arylcyclohexylamine derivatives and their use in the treatment of psychiatric disorders Patent WO 2021/134086 A1, 1 Jul 2021. 19.8 MB. #35 LC,MS,NMR